Comparative Drug Resistance Reversal Potential of Natural Glycosides: Potential of Synergy Niaziridin & Niazirin

被引:10
作者
Dwivedi, Gaurav R. [1 ,5 ]
Maurya, Anupam [2 ,6 ]
Yadav, Dharmendra K. [3 ,7 ]
Khan, Feroz [3 ]
Gupta, Mahendra K. [4 ]
Gupta, Prashant [4 ]
Darokar, Mahendra P. [1 ]
Srivastava, Santosh K. [2 ]
机构
[1] Cent Inst Med & Aromat Plants, CSIR, Mol Bioprospect Dept, PO CIMAP,Kukrail Picn Spot Rd, Lucknow 226015, Uttar Pradesh, India
[2] Cent Inst Med & Aromat Plants, CSIR, Med Chem Dept, Lucknow 226015, Uttar Pradesh, India
[3] Cent Inst Med & Aromat Plants, CSIR, Metab & Struct Biol, Lucknow 226015, Uttar Pradesh, India
[4] King George Med Univ, Dept Microbiol, Lucknow, Uttar Pradesh, India
[5] ICMR Reg Med Res Ctr, Microbiol Dept, Bhubaneswar 751023, Odisha, India
[6] PCIM&H, PLIM Campus, Ghaziabad 201002, India
[7] Gachon Univ, Coll Pharm, Hambakmoeiro 191, Incheon 406799, South Korea
关键词
MDR; Glycosides; Niaziridin; Niazirin; Antibacterial combinations; Drug resistance; MULTIDRUG EFFLUX PUMPS; DOCKING BASED SEMISYNTHESIS; IN-VITRO EVALUATION; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ACID-DERIVATIVES; ANTIBIOTIC-RESISTANCE; ANTIBACTERIAL DRUGS; MORINGA-OLEIFERA; INHIBITORS;
D O I
10.2174/1568026619666190412120008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Due to the limited availability of antibiotics, Gram-negative bacteria (GNB) acquire different levels of drug resistance. It raised an urgent need to identify such agents, which can reverse the phenomenon of drug resistance. Objective: To understand the mechanism of drug resistance reversal of glycosides; niaziridin and niazirin isolated from the pods of Moringa oleifera and ouabain (control) against the clinical isolates of multidrug-resistant Escherichia coli. Methods: The MICs were determined following the CLSI guidelines for broth micro-dilution. In-vitro combination studies were performed by broth checkerboard method followed by Time-Kill studies, the efflux pump inhibition assay, ATPase inhibitory activity, mutation prevention concentration and in-silico studies. Results: The results showed that both glycosides did not possess antibacterial activity of their own, but in combination, they reduced the MIC of tetracycline up to 16 folds. Both were found to inhibit efflux pumps, but niaziridin was the best. In real time expression pattern analysis, niaziridin was also found responsible for the down expression of the two important efflux pump acrB & you genes alone as well as in combination. Niaziridin was also able to over express the porin forming genes (ompA & ompX). These glycosides decreased the mutation prevention concentration of tetracycline. Conclusion: This is the first ever report on glycosides, niazirin and niaziridin acting as drug resistance reversal agent through efflux pump inhibition and modulation of expression pattern drug resistant genes. This study may be helpful in preparing an effective antibacterial combination against the drug-resistant GNB from a widely growing Moringa oleifera.
引用
收藏
页码:847 / 860
页数:14
相关论文
共 97 条
[41]   In 2035, will all bacteria be multidrug resistant? We are not sure [J].
Laupland, Kevin B. ;
Ruppe, Etienne ;
Harbarth, Stephan .
INTENSIVE CARE MEDICINE, 2016, 42 (12) :2021-2023
[42]  
Lewis K, 2001, J MOL MICROB BIOTECH, V3, P247
[43]   Introduction: the challenge of multiresistance [J].
Livermore, David M. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 :S1-S7
[44]   Practical applications and feasibility of efflux pump inhibitors in the clinic - A vision for applied use [J].
Lomovskaya, O ;
Bostian, KA .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (07) :910-918
[45]   Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:: Novel agents for combination therapy [J].
Lomovskaya, O ;
Warren, MS ;
Lee, A ;
Galazzo, J ;
Fronko, R ;
Lee, M ;
Blais, J ;
Cho, D ;
Chamberland, S ;
Renau, T ;
Leger, R ;
Hecker, S ;
Watkins, W ;
Hoshino, K ;
Ishida, H ;
Lee, VJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :105-116
[46]   Carbapenem-Resistant Enterobacteriaceae [J].
Lovleva, Alina ;
Doi, Yohei .
CLINICS IN LABORATORY MEDICINE, 2017, 37 (02) :303-+
[47]  
Luqman S, 2007, ALTERN THER HEALTH M, V13, P54
[48]   Antibiotic efflux pumps in Gram-negative bacteria:: the inhibitor response strategy [J].
Mahamoud, Abdallah ;
Chevalier, Jacqueline ;
Alibert-Franco, Sandrine ;
Kern, Winfried V. ;
Pages, Jean-Marie .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) :1223-1229
[49]   Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities [J].
Martins, Marta ;
Dastidar, Sujata G. ;
Fanning, Seamus ;
Kristiansen, Jette E. ;
Molnar, Joseph ;
Pages, Jean-Marie ;
Schelz, Zsuzsanna ;
Spengler, Gabriella ;
Viveiros, Miguel ;
Amaral, Leonard .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (03) :198-208
[50]  
Martins M, 2010, METHODS MOL BIOL, V642, P143, DOI 10.1007/978-1-60327-279-7_11